Stage IIIC epithelial ovarian cancer classified solely by lymph node metastasis has a more favorable prognosis than other types of stage IIIC epithelial ovarian cancer - Test2 - elhamkhani - TriplyDB

Stage IIIC epithelial ovarian cancer classified solely by lymph node metastasis has a more favorable prognosis than other types of stage IIIC epithelial ovarian cancer

Stage IIIC epithelial ovarian cancer classified solely by lymph node metastasis has a more favorable prognosis than other types of stage IIIC epithelial ovarian cancer

http://www.wikidata.org/entity/Q37177699

about

Successful management of mucinous ovarian cancer by conservative surgery in week 6 of pregnancy: case report and literature review What is the role of retroperitoneal exploration in optimally debulked stage IIIC epithelial ovarian cancer? An NRG Oncology/Gynecologic Oncology Group ancillary data study.Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.Survival analysis of revised 2013 FIGO staging classification of epithelial ovarian cancer and comparison with previous FIGO staging classification Targeting HSP90 in ovarian cancers with multiple receptor tyrosine kinase coactivation.Systematic lymphadenectomy in the treatment of epithelial ovarian cancer: a meta-analysis of multiple epidemiology studies.FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication.Should we modify the current FIGO staging system for stage IIIC ovarian cancer?Improvements to the FIGO staging for ovarian cancer: reconsideration of lymphatic spread and intraoperative tumor rupture.EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinoma Revised FIGO staging system for cancer of the ovary, fallopian tube, and peritoneum: important implications for radiologists.Enhancement of triptolide-loaded micelles on tumorigenicity inhibition of human ovarian cancer.Anti-Sp17 monoclonal antibody-doxorubicin conjugates as molecularly targeted chemotherapy for ovarian carcinoma.The prognostic impact of the ratio of positive lymph nodes on survival of epithelial ovarian cancer patients.Distinct preoperative clinical features predict four histopathological subtypes of high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum.Eighth Edition of the UICC Classification of Malignant Tumours: an overview of the changes in the pathological TNM classification criteria-What has changed and why?Lymph node metastases as only qualifier for stage IV serous ovarian cancer confers longer survival than other sites of distant disease - a Swedish Gynecologic Cancer Group (SweGCG) study.Does the primary route of spread have a prognostic significance in stage III non-serous epithelial ovarian cancer?

P2860

Q26830718-1FD49469-8A99-4252-B6E0-F8267EA802C0 Q31143363-44B9E9C2-79B4-4B94-BF46-7FC11085A9F7 Q33457920-9177C81F-6CE6-4A0D-ABC5-AC71E20E8772 Q35198222-1AA9EA26-83D8-429C-875A-C98B7566C3D6 Q35390011-D8170394-8EC6-417C-9D36-3CA32D973B51 Q35411097-C3AF37FC-5EEA-4137-A0D3-1752D6C91740 Q35419216-59A41DEB-512F-4E6B-BDA2-A21F1DC43600 Q37177708-2C21B313-9C9E-48E1-ADE5-68258E79A80D Q37249307-99C98822-124A-414D-91EE-71F3FB48C81D Q37329160-C6B5F26F-6F00-47CA-89EE-3301F8BFCA57 Q38676869-E3541F5A-A01C-4B85-BADC-E6328AAD2E7E Q38801615-01693230-F19A-4FB5-B389-6AA82F129655 Q39110485-DFBF5260-7D40-4388-A9FB-47D88E89BEBB Q39793145-7235E90C-0EEB-401B-9500-665D15ACCB35 Q41557623-A78D1900-6CF6-4A3A-8673-F53033D24DE5 Q47361459-86CE3CB9-E621-464E-A118-E1FF71D9F9F4 Q48318844-AD1B238C-66DB-4BA4-A2BC-314E989EF87E Q52728811-2FFB7175-9E38-45EB-9536-724BDFF9657A

P2860

Stage IIIC epithelial ovarian cancer classified solely by lymph node metastasis has a more favorable prognosis than other types of stage IIIC epithelial ovarian cancer

http://www.wikidata.org/entity/Q37177699

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Stage IIIC epithelial ovarian ...... IIIC epithelial ovarian cancer

@en

Stage IIIC epithelial ovarian ...... IIC epithelial ovarian cancer.

@nl

type

label

Stage IIIC epithelial ovarian ...... IIIC epithelial ovarian cancer

@en

Stage IIIC epithelial ovarian ...... IIC epithelial ovarian cancer.

@nl

prefLabel

Stage IIIC epithelial ovarian ...... IIIC epithelial ovarian cancer

@en

Stage IIIC epithelial ovarian ...... IIC epithelial ovarian cancer.

@nl

P1433

Q37177699-F21F847F-179E-4092-9818-17717A8203D0

P1476

Q37177699-34F36B3E-28B8-4F12-8F74-7823A7D0C134

P2093

Q37177699-97D41D4B-7A28-414F-ABB8-09AA49DEFF71

Q37177699-9C7C69A1-8374-43D0-AF15-E88E75EC7AC4

Q37177699-9C96D03F-C045-4D76-95E5-8B0FB26211A7

Q37177699-B274729D-5534-4E1C-BE06-CF5B4D01D419

Q37177699-C2E8830B-F1AE-4414-860E-DDB5669FC0F8

Q37177699-D4C5C853-A090-4989-9D33-2AEBB0C5FBA1

Q37177699-F1166E12-146C-4B70-BCA4-74496039BAC9

P2860

Q37177699-36A76DBE-527B-4B75-AF92-9392723E5EE7

Q37177699-8CF75D59-EB17-45A9-BB0F-FB5E8C07BD2D

Q37177699-8F4C61C6-4ACC-4C7B-9ED5-28D0F6F891D2

Q37177699-92CE7E24-7891-4A21-9063-FCD87C021174

Q37177699-A0BA662A-A29E-4B8B-A8E7-0AA5BBB6C40C

Q37177699-B73E23BE-B96C-41B1-8F38-A01AD9A10BC7

Q37177699-E468E1A8-CE60-496E-B19F-CDC6CD3D2338

P304

Q37177699-71E95FF2-DE2E-463C-8DF1-66D5602A229A

P31

Q37177699-39A03DE6-3650-4D51-B22E-4916B7120A20

P356

Q37177699-8AA80006-F5B6-4206-8997-D422CCF2EE19

P433

Q37177699-584F396C-D008-4D2D-AE73-1E59E6A649F2

P478

Q37177699-09D48EA2-7F1B-428A-88FB-5B9E310658E7

P577

Q37177699-0D6141F4-4B96-4059-A4FD-A26A3B3C7C7F

P5875

Q37177699-2930F226-A110-40AD-BBF9-3A8230E5DEC2

P698

Q37177699-E997A172-E537-4D4F-946F-A840A5DA93E8

P921

Q37177699-774DCB18-4AE9-4F09-92E6-487A9A32E610

Q37177699-79B54CB3-5599-4702-82A9-5EBC9D14CE52

P932

Q37177699-FF891229-C736-43B0-BF55-A851CDC35ED9

P356

JGO.2008.19.4.223

P1433

Journal of gynecologic oncology

P1476

Stage IIIC epithelial ovarian ...... IIIC epithelial ovarian cancer

@en

P2093

Dae-Yeon Kim

http://www.w3.org/2001/XMLSchema#string

Jeong-Yeol Park

http://www.w3.org/2001/XMLSchema#string

Jong-Hyeok Kim

http://www.w3.org/2001/XMLSchema#string

Joo-Hyun Nam

http://www.w3.org/2001/XMLSchema#string

Su-Jin Baek

http://www.w3.org/2001/XMLSchema#string

Yong-Man Kim

http://www.w3.org/2001/XMLSchema#string

Young-Tak Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2006

Evaluation of survival data and two new rank order statistics arising in its consideration.

The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study.

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer.

Significance of lymph node sampling in epithelial carcinoma of the ovary.

Cytoreductive surgery in advanced epithelial cancer of the ovary: the impact of aortic and pelvic lymphadenectomy.

Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only?

P304

223-228

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3802/JGO.2008.19.4.223

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2008-12-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26242999

http://www.w3.org/2001/XMLSchema#string

P698

19471577

http://www.w3.org/2001/XMLSchema#string

P921

P932

2676474

http://www.w3.org/2001/XMLSchema#string